6 February 2019
BIOS appoints Paul Hughes as COO to scale the company and lead its international expansion
BIOS, the leading neural engineering startup, has appointed Paul Hughes as its new Chief Operating Officer (COO). An advisor to the company since 2015, Hughes will now be working full-time to help BIOS scale following its $4.5M USD seed round and the opening of a new office in Montreal, Canada.
Co-founded by computational neuroscientist Emil Hewage and bioengineer Oliver Armitage, BIOS is developing neural interfaces to enable artificial intelligence-based treatments on organs and nerve systems throughout the body. Hughes will be based in the company's headquarters in Cambridge, UK, but will also oversee operations in the newly established Canadian office in Montreal.
Hughes specialises in scaling technology businesses of all sizes around the world, primarily working with strategy, fundraising and corporate development. He has run incubators and accelerators worldwide, working with a number of high-growth startups as well as established companies. In the 1980s, he joined Twyford International as Financial Analyst to lead the international AgBiotech (agriculture biotechnology) business. He then moved to New York where he worked as Vice President and Chief Financial Officer (CFO) at AgriCapital Corporation, an international investment bank focusing on middle market transactions, advising clients on corporate development around the world.
In 2002, he co-founded TMO Renewables, a pioneering biofuel startup in the UK. Most recently, Hughes established Allia’s Serious Impact division to incubate and accelerate impact ventures.
Emil Hewage, Co-Founder and CEO at BIOS, commented: “Paul is one of our long-trusted advisors and we are thrilled to have him come on board full time. We are fortunate to be attracting accomplished and experienced new team members from across the world and Paul’s joining-us is another welcome vote of confidence in both the quality of the team we are building at BIOS and the value of the problem we are working to tackle. This role will underpin and support the accelerated pace of growth at BIOS and allow us to achieve greater impact through our combined efforts in the years to come.”
Paul Hughes, COO at BIOS, said: “I have been advising Emil and Oliver since the very beginnings of BIOS. They are exceptional entrepreneurs and technical innovators. BIOS has the potential to become a true disruptor in the health sector and when the opportunity arose to join in a full-time role, I was thrilled to accept.”